1 |
33297669 |
10.3324/haematol.2020.267294 |
2022 |
Phenogenomic heterogeneity of post-transplant plasmablastic lymphomas. |
SOCS1 |
2 |
34265801 |
10.1097/PAS.0000000000001780 |
2022 |
Plasticity of Mature B Cells Between Follicular and Classic Hodgkin Lymphomas: A Series of 22 Cases Expanding the Spectrum of Transdifferentiation. |
SOCS1 |
3 |
34714908 |
10.1182/bloodadvances.2021005486 |
2022 |
Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways. |
SOCS1 |
4 |
34791836 |
10.1002/cam4.4422 |
2022 |
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. |
SOCS1 |
5 |
35075971 |
10.1080/10428194.2021.2010060 |
2022 |
Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study. |
SOCS1 |
6 |
35205765 |
10.3390/cancers14041018 |
2022 |
Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study. |
SOCS1 |
7 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
SOCS1 |
8 |
35600392 |
10.3389/fonc.2022.881801 |
2022 |
SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer. |
SOCS1 |
9 |
35879731 |
10.1186/s40364-022-00401-4 |
2022 |
Dynamic change of soluble interleukin-2 receptor distinguished molecular heterogeneity and microenvironment alterations in diffuse large B-cell lymphoma. |
SOCS1 |
10 |
35885481 |
10.3390/diagnostics12071575 |
2022 |
Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma. |
SOCS1 |
11 |
32079702 |
10.3324/haematol.2019.237719 |
2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. |
SOCS1 |
12 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
SOCS1 |
13 |
33684939 |
10.1182/blood.2020007683 |
2021 |
Characterization of DLBCL with a PMBL gene expression signature. |
SOCS1 |
14 |
33899787 |
10.1097/PAS.0000000000001691 |
2021 |
The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma. |
SOCS1 |
15 |
33951889 |
10.3324/haematol.2020.271957 |
2021 |
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. |
SOCS1 |
16 |
34039950 |
10.1038/s41408-021-00493-5 |
2021 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
SOCS1 |
17 |
34272731 |
10.1111/bjh.17708 |
2021 |
EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. |
SOCS1 |
18 |
34312841 |
10.1111/bjh.17719 |
2021 |
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping. |
SOCS1 |
19 |
34405005 |
10.7150/jca.60390 |
2021 |
Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. |
SOCS1 |
20 |
34925435 |
10.3389/fgene.2021.677650 |
2021 |
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing. |
SOCS1 |
21 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
SOCS1 |
22 |
31774495 |
10.1182/blood.2019001904 |
2020 |
Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. |
SOCS1 |
23 |
32239385 |
10.1007/s11523-020-00710-4 |
2020 |
Genomic Alterations and MYD88<sup>MUT</sup> Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib. |
SOCS1 |
24 |
32555149 |
10.1038/s41408-020-0335-0 |
2020 |
CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma. |
SOCS1 |
25 |
32947237 |
10.1016/j.tranon.2020.100855 |
2020 |
Identification of clinical molecular targets for childhood Burkitt lymphoma. |
SOCS1 |
26 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
SOCS1 |
27 |
30211726 |
10.1097/PAS.0000000000001154 |
2019 |
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease. |
SOCS1 |
28 |
30213827 |
10.3324/haematol.2018.203224 |
2019 |
<i>JUNB</i>, <i>DUSP2</i>, <i>SGK1</i>, <i>SOCS1</i> and <i>CREBBP</i> are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma. |
SOCS1 |
29 |
31305266 |
10.1097/PAS.0000000000001324 |
2019 |
Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With Hodgkin/Reed-Sternberg-like Cells of NK Phenotype. |
SOCS1 |
30 |
29650799 |
10.1182/blood-2017-11-814913 |
2018 |
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. |
SOCS1 |
31 |
30054295 |
10.1182/blood-2018-01-829424 |
2018 |
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma. |
SOCS1 |
32 |
30087457 |
10.1038/s41374-018-0096-6 |
2018 |
Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. |
SOCS1 |
33 |
28302137 |
10.1186/s13045-017-0438-7 |
2017 |
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort. |
SOCS1 |
34 |
27198204 |
10.1038/leu.2016.135 |
2016 |
Distinct genetic evolution patterns of relapsing diffuse large B-cell lymphoma revealed by genome-wide copy number aberration and targeted sequencing analysis. |
SOCS1 |
35 |
26599546 |
10.1371/journal.pone.0139663 |
2015 |
Genomic Landscape of Primary Mediastinal B-Cell Lymphoma Cell Lines. |
SOCS1 |
36 |
22387553 |
10.4049/jimmunol.1102899 |
2012 |
Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. |
SOCS1 |
37 |
10856136 |
10.1067/mai.2000.107604 |
2000 |
IL-4/IL-13 signaling beyond JAK/STAT. |
SOCS1 |